Back to top

Jeet Mukherjee Reiterates Buy on Bicara, Maintains $28 Price Target on Differentiated Ficera Profile and Upside Potential

Analyst Jeet Mukherjee from BTIG maintained a Buy rating on Bicara Therapeutics Inc. and keeping the price target at $28.00. Jeet Mukherjee has giv...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: